Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$12.42 - $15.62 $31,050 - $39,050
2,500 Added 4.86%
53,900 $38,000
Q3 2022

Nov 14, 2022

BUY
$12.8 - $28.65 $3,840 - $8,595
300 Added 0.59%
51,400 $9,000
Q2 2022

Aug 12, 2022

SELL
$13.12 - $15.03 $1.16 Million - $1.33 Million
-88,400 Reduced 63.37%
51,100 $30,000
Q1 2022

May 12, 2022

SELL
$13.54 - $15.35 $3.73 Million - $4.23 Million
-275,300 Reduced 66.37%
139,500 $56,000
Q4 2021

Feb 14, 2022

BUY
$13.17 - $16.4 $1.21 Million - $1.51 Million
92,000 Added 28.5%
414,800 $33,000
Q3 2021

Nov 10, 2021

SELL
$16.3 - $17.26 $89,650 - $94,930
-5,500 Reduced 1.68%
322,800 $128,000
Q2 2021

Aug 11, 2021

BUY
$16.55 - $18.64 $5.43 Million - $6.12 Million
328,300 New
328,300 $233,000
Q1 2021

May 14, 2021

SELL
$16.71 - $19.9 $9.07 Million - $10.8 Million
-543,027 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$15.39 - $18.97 $8.36 Million - $10.3 Million
543,027 New
543,027 $314,000
Q3 2020

Nov 13, 2020

SELL
$17.1 - $19.19 $9.33 Million - $10.5 Million
-545,427 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$14.59 - $19.5 $7.96 Million - $10.6 Million
545,427 New
545,427 $858,000
Q4 2019

Feb 11, 2020

SELL
$16.88 - $20.83 $8.77 Million - $10.8 Million
-519,627 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$16.15 - $17.99 $34,011 - $37,886
-2,106 Reduced 0.4%
519,627 $889,000
Q2 2019

Aug 14, 2019

BUY
$16.58 - $20.49 $4.4 Million - $5.43 Million
265,109 Added 103.31%
521,733 $1.1 Million
Q1 2019

May 10, 2019

BUY
$16.7 - $21.52 $4.29 Million - $5.52 Million
256,624 New
256,624 $260,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.